Historical Stock Price
MDGL historical stock prices picture
Madrigal Pharmaceuticals (MDGL) has the following price history information. Looking back at MDGL historical stock prices for the last five trading days, on March 21, 2024, MDGL opened at $261.64, traded as high as $265.79 and as low as $251.79, and closed at $255.27. Trading volume was a total of 382.30K shares. On March 22, 2024, MDGL opened at $258.49, traded as high as $259.95 and as low as $242.38, and closed at $248.20. Trading volume was a total of 529.90K shares. On March 25, 2024, MDGL opened at $248.85, traded as high as $257.73 and as low as $246.54, and closed at $247.62. Trading volume was a total of 394.40K shares. On March 26, 2024, MDGL opened at $247.00, traded as high as $252.00 and as low as $246.61, and closed at $247.62. Trading volume was a total of 234.10K shares. On March 27, 2024, MDGL opened at $250.00, traded as high as $259.55 and as low as $244.81, and closed at $258.81. Trading volume was a total of 442.70K shares.

MDGL Historical Stock Prices By Date:

MDGL historical cagr picture

Below, we examine the compound annual growth rate — CAGR for short — of an investment into Madrigal Pharmaceuticals shares, starting with a $10,000 purchase of MDGL, and working forward through the historical stock price information to today.

Growth of $10,000.00
Without Dividends Reinvested

Start date: 03/31/2014
End date: 03/27/2024
Start price/share: $150.85
End price/share: $258.81
Dividends collected/share: $0.00
Total return: 71.57%
Average Annual Total Return: 5.55%
Starting investment: $10,000.00
Ending investment: $17,160.03
Years: 10.00
Date Open High Low Close Volume
03/21/2024 $261.64 $265.79 $251.79 $255.27 382.30K
03/22/2024 $258.49 $259.95 $242.38 $248.20 529.90K
03/25/2024 $248.85 $257.73 $246.54 $247.62 394.40K
03/26/2024 $247.00 $252.00 $246.61 $247.62 234.10K
03/27/2024 $250.00 $259.55 $244.81 $258.81 442.70K
Madrigal Pharmaceuticals is a clinical-stage biopharmaceutical company focused on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Co.'s primary product candidate, resmetirom, is being developed as a once-daily oral pill to treat several disease states, including non-alcoholic steatohepatitis, or NASH. Co. has initiated MAESTRO-NASH, a Phase 3 trial in NASH with its once daily, oral thyroid hormone receptor beta selective agonist, resmetirom. Co. has opened for enrollment MAESTRO-NAFLD-1, a Phase 3 clinical study of patients with biopsy-confirmed or presumed NASH recruited from sites in the U.S.
Date Close
03/21/2024$255.27
03/22/2024$248.20
03/25/2024$247.62
03/26/2024$247.62
03/27/2024$258.81
MDGL is categorized under the Healthcare sector; below are some other companies in the same sector:

MDGN Historical Stock Prices
MDT Historical Stock Prices
MDVN Historical Stock Prices
MDVX Historical Stock Prices
MDX Historical Stock Prices
MDXG Historical Stock Prices
MEIP Historical Stock Prices
MELA Historical Stock Prices
MGCD Historical Stock Prices
MGEN Historical Stock Prices

Also explore: MDGL shares outstanding history

Email EnvelopeFree MDGL Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts


MDGL Historical Stock Prices | www.HistoricalStockPrice.com | Copyright © 2013 - 2024, All Rights Reserved

Nothing in www.HistoricalStockPrice.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 9.5%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 9.5%.